{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:11:10Z","timestamp":1781629870210,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000362","name":"Asthma and Lung UK","doi-asserted-by":"publisher","award":["DJF25\\28"],"award-info":[{"award-number":["DJF25\\28"]}],"id":[{"id":"10.13039\/501100000362","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Imperial-ARUA Research Seed Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There is growing evidence suggesting that lung capacity is associated with risk of cardiometabolic disease. However, most studies rely on spirometric measures of lung capacity and self-reported cardiometabolic disease. We aimed to investigate the association of total lung capacity (TLC) with cardiometabolic disease defined using ICD-10 codes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from adult patients referred to Cambridge University Hospitals between 2016 and 2024 were used if spirometry, single breath gas transfer, and body plethysmography were performed in the same session. GLI reference equations were used to generate z-scores for lung function measures. ICD-10 codes for cardiovascular disease, hypertension, and diabetes were extracted from medical records. We used multi-level (mixed-effects) Cox regression analysis to investigate the association between lung function measurements and incident cardiometabolic disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      5628 patients were included, 51% were female, with a median age of 62 (IQR 50\u201370) years. 60% reported a smoking history. Mean follow-up time was 5.7 (SD 2.3) years, during which time 5% received a cardiovascular disease code, 7% a hypertension code, and 3% a diabetes code. A 1-unit increment in TLC z-score was associated with a 12% lower risk of cardiovascular disease (HR: 0.88, 95%CI 0.80\u20130.97) later in life. The same was seen for FVC (HR: 0.88, 95%CI 0.77\u20130.99) but not FEV\n                      <jats:sub>1<\/jats:sub>\n                      \/FVC or DLCO. A larger TLC was also associated with lower risk of myocardial infarction. We found no association of lung function measures with incident hypertension or diabetes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Lung capacity is a determinant for cardiovascular disease and myocardial infarction, with larger lungs being protective. TLC and FVC should be considered by clinicians along with other factors, when evaluating a person\u2019s risk of cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-026-03502-y","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:53:06Z","timestamp":1768276386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lung capacity is a determinant of cardiovascular disease and myocardial infarction"],"prefix":"10.1186","volume":"27","author":[{"given":"Ben","family":"Knox-Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Sibomana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl P","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.S.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"3502_CR1","unstructured":"ONS. Deaths registered in England and Wales: 2023 2024 [Office for National Statistics (ONS) statistical bulletin]. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsregistrationsummarytables\/2023"},{"key":"3502_CR2","doi-asserted-by":"crossref","unstructured":"Naghavi M, Ong KL, Aali A, Ababneh HS, Abate YH, Abbafati C, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403(10440):2100-32.","DOI":"10.1016\/S0140-6736(24)00367-2"},{"key":"3502_CR3","doi-asserted-by":"publisher","first-page":"1008335","DOI":"10.3389\/fcvm.2022.1008335","volume":"9","author":"NW Minja","year":"2022","unstructured":"Minja NW, Nakagaayi D, Aliku T, Zhang W, Ssinabulya I, Nabaale J, et al. Cardiovascular diseases in Africa in the twenty-first century: gaps and priorities going forward. Front Cardiovasc Med. 2022;9:1008335.","journal-title":"Front Cardiovasc Med"},{"issue":"14","key":"3502_CR4","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/eurjpc\/zwae219","volume":"31","author":"F Zhu","year":"2024","unstructured":"Zhu F, Boersma E, Tilly M, Ikram MK, Qi H, Kavousi M. Trends in population attributable fraction of modifiable risk factors for cardiovascular diseases across three decades. Eur J Prev Cardiol. 2024;31(14):1724\u201333.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"3502_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12931-022-01939-5","volume":"23","author":"K Kulbacka-Ortiz","year":"2022","unstructured":"Kulbacka-Ortiz K, Triest FJJ, Franssen FME, Wouters EFM, Studnicka M, Vollmer WM, et al. Restricted spirometry and cardiometabolic comorbidities: results from the international population based BOLD study. Respir Res. 2022;23(1):34.","journal-title":"Respir Res"},{"key":"3502_CR6","doi-asserted-by":"crossref","unstructured":"Janson C, Potts J, Malinovschi A, Agarwal D, Ahmed R, Aquart-Stewart A et al. Lung function and onset of cardiometabolic diseases in the longitudinal burden of obstructive lung disease study. BMJ Open Respir Res. 2025;12(1).","DOI":"10.1136\/bmjresp-2024-002442"},{"issue":"12","key":"3502_CR7","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.rmed.2015.10.016","volume":"109","author":"AF Amaral","year":"2015","unstructured":"Amaral AF, Patel J, Gnatiuc L, Jones M, Burney PG. Association of pulse wave velocity with total lung capacity: A cross-sectional analysis of the BOLD London study. Respir Med. 2015;109(12):1569\u201375.","journal-title":"Respir Med"},{"issue":"20","key":"3502_CR8","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1161\/01.CIR.0000037220.00065.0D","volume":"106","author":"G Engstr\u00f6m","year":"2002","unstructured":"Engstr\u00f6m G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation. 2002;106(20):2555\u201360.","journal-title":"Circulation"},{"issue":"3","key":"3502_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/thorax-2023-220703","volume":"79","author":"L Zhou","year":"2024","unstructured":"Zhou L, Yang H, Zhang Y, Wang Y, Zhou X, Liu T, et al. Predictive value of lung function measures for cardiovascular risk: a large prospective cohort study. Thorax. 2024;79(3):250\u20138.","journal-title":"Thorax"},{"issue":"2","key":"3502_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0002-8703(83)90532-X","volume":"105","author":"WB Kannel","year":"1983","unstructured":"Kannel WB, Hubert H, Lew EA. Vital capacity as a predictor of cardiovascular disease: the Framingham study. Am Heart J. 1983;105(2):311\u20135.","journal-title":"Am Heart J"},{"issue":"7","key":"3502_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/thx.2007.088112","volume":"63","author":"AK Johnston","year":"2008","unstructured":"Johnston AK, Mannino DM, Hagan GW, Davis KJ, Kiri VA. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63(7):599\u2013605.","journal-title":"Thorax"},{"issue":"1","key":"3502_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1590\/S1679-45082014RW2691","volume":"12","author":"LC Melo","year":"2014","unstructured":"Melo LC, Silva MA, Calles AC. Obesity and lung function: a systematic review. Einstein (Sao Paulo). 2014;12(1):120\u20135.","journal-title":"Einstein (Sao Paulo)"},{"key":"3502_CR13","doi-asserted-by":"crossref","unstructured":"Bhakta NR, McGowan A, Ramsey KA, Borg B, Kivastik J, Knight SL et al. European respiratory society\/American thoracic society technical statement: standardisation of the measurement of lung volumes, 2023 update. Eur Respir J. 2023;62(4).","DOI":"10.1183\/13993003.01519-2022"},{"issue":"8","key":"3502_CR14","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 Update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70\u201388.","journal-title":"Am J Respir Crit Care Med"},{"key":"3502_CR15","doi-asserted-by":"crossref","unstructured":"Graham BL, Brusasco V, Burgos F, Cooper BG, Jensen R, Kendrick A et al. 2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49(1).","DOI":"10.1183\/13993003.00016-2016"},{"issue":"6","key":"3502_CR16","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324\u201343.","journal-title":"Eur Respir J"},{"key":"3502_CR17","doi-asserted-by":"crossref","unstructured":"Hall GL, Filipow N, Ruppel G, Okitika T, Thompson B, Kirkby J et al. Official ERS technical standard: global lung function initiative reference values for static lung volumes in individuals of European ancestry. Eur Respir J. 2021;57(3).","DOI":"10.1183\/13993003.00289-2020"},{"key":"3502_CR18","doi-asserted-by":"crossref","unstructured":"Stanojevic S, Graham BL, Cooper BG, Thompson BR, Carter KW, Francis RW et al. Official ERS technical standards: global lung function initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J. 2017;50(3).","DOI":"10.1183\/13993003.00010-2017"},{"issue":"11","key":"3502_CR19","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1164\/rccm.202005-1990OC","volume":"203","author":"P Burney","year":"2021","unstructured":"Burney P, Patel J, Minelli C, Gnatiuc L, Amaral AFS, Kocaba\u015f A, et al. Prevalence and Population-Attributable risk for chronic airflow obstruction in a large multinational study. Am J Respir Crit Care Med. 2021;203(11):1353\u201365.","journal-title":"Am J Respir Crit Care Med"},{"key":"3502_CR20","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.ajpc.2021.100149","volume":"5","author":"HE Bays","year":"2021","unstructured":"Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, et al. Ten things to know about ten cardiovascular disease risk factors. Am J Prev Cardiol. 2021;5:100149.","journal-title":"Am J Prev Cardiol"},{"issue":"3","key":"3502_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1590\/S1806-37132013000300008","volume":"39","author":"AR Barros","year":"2013","unstructured":"Barros AR, Pires MB, Raposo NM. Importance of slow vital capacity in the detection of airway obstruction. J Bras Pneumol. 2013;39(3):317\u201322.","journal-title":"J Bras Pneumol"},{"issue":"7","key":"3502_CR22","doi-asserted-by":"publisher","first-page":"e023422","DOI":"10.1161\/JAHA.121.023422","volume":"11","author":"HC Chang","year":"2022","unstructured":"Chang HC, Huang WM, Yu WC, Cheng HM, Guo CY, Chiang CE, et al. Prognostic role of pulmonary function in patients with heart failure with reduced ejection fraction. J Am Heart Assoc. 2022;11(7):e023422.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"3502_CR23","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1378\/chest.98.4.816","volume":"98","author":"RS Wright","year":"1990","unstructured":"Wright RS, Levine MS, Bellamy PE, Simmons MS, Batra P, Stevenson LW, et al. Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest. 1990;98(4):816\u201320.","journal-title":"Chest"},{"issue":"10","key":"3502_CR24","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jacc.2018.06.049","volume":"72","author":"OM Silvestre","year":"2018","unstructured":"Silvestre OM, Nadruz W Jr., Querejeta Roca G, Claggett B, Solomon SD, Mirabelli MC, et al. Declining lung function and cardiovascular risk: the ARIC study. J Am Coll Cardiol. 2018;72(10):1109\u201322.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3502_CR25","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1046\/j.1365-2796.2003.01138.x","volume":"253","author":"G Engstr\u00f6m","year":"2003","unstructured":"Engstr\u00f6m G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med. 2003;253(5):574\u201381.","journal-title":"J Intern Med"},{"issue":"2","key":"3502_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.chest.2021.12.663","volume":"162","author":"G Li","year":"2022","unstructured":"Li G, Lu Y, Qiao Y, Hu D, Ke C. Role of pulmonary function in predicting New-Onset cardiometabolic diseases and cardiometabolic Multimorbidity. Chest. 2022;162(2):421\u201332.","journal-title":"Chest"},{"issue":"5","key":"3502_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S2213-2600(23)00091-7","volume":"11","author":"P Burney","year":"2023","unstructured":"Burney P, Knox-Brown B, Amaral AFS. Small lung syndrome: the need to reclassify chronic lung disease. Lancet Respiratory Med. 2023;11(5):405\u20136.","journal-title":"Lancet Respiratory Med"},{"key":"3502_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.rmed.2018.07.011","volume":"142","author":"E Nerpin","year":"2018","unstructured":"Nerpin E, Jacinto T, Fonseca JA, Alving K, Janson C, Malinovschi A. Systemic inflammatory markers in relation to lung function in NHANES. 2007\u20132010. Respir Med. 2018;142:94\u2013100.","journal-title":"Respir Med"},{"issue":"2","key":"3502_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/HYPERTENSIONAHA.111.184101","volume":"59","author":"DR Jacobs Jr","year":"2012","unstructured":"Jacobs DR Jr., Yatsuya H, Hearst MO, Thyagarajan B, Kalhan R, Rosenberg S, et al. Rate of decline of forced vital capacity predicts future arterial hypertension: the coronary artery risk development in young adults study. Hypertension. 2012;59(2):219\u201325.","journal-title":"Hypertension"},{"issue":"9","key":"3502_CR30","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1464-5491.2010.03073.x","volume":"27","author":"OL Klein","year":"2010","unstructured":"Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review of the association between lung function and type 2 diabetes mellitus. Diabet Med. 2010;27(9):977\u201387.","journal-title":"Diabet Med"},{"issue":"9","key":"3502_CR31","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.2337\/dc10-0324","volume":"33","author":"SG Wannamethee","year":"2010","unstructured":"Wannamethee SG, Shaper AG, Rumley A, Sattar N, Whincup PH, Thomas MC, et al. Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation. Diabetes Care. 2010;33(9):1990\u20136.","journal-title":"Diabetes Care"},{"issue":"1","key":"3502_CR32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12890-022-02208-3","volume":"22","author":"W Li","year":"2022","unstructured":"Li W, Ning Y, Ma Y, Lin X, Man S, Wang B, et al. Association of lung function and blood glucose level: a 10-year study in China. BMC Pulm Med. 2022;22(1):444.","journal-title":"BMC Pulm Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03502-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03502-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03502-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:39:07Z","timestamp":1781627947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03502-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3502"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03502-y","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval to use the data was provided by the EHR Research and Innovation (ERIN) database data access committee (IRAS: 318784, study reference: A096987). As this was a retrospective analysis of routinely collected hospital data, individual participant consent was not required. However, patients who had opted out of their data being used for research purposes were removed prior to analysis. Research was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KS receives consultation fees from ndd medical. All other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}